The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Bang game on
Small top up today, plenty trading around this level.
Somebody sold 400,000 shares at 1600 today, might have had an impact.
movements again...
Management expects to increase sales by 5 times when 2021 comes around and today result didn�t help their cause. The fall in revenue came from lower sales in North America and Asia. The first six-month saw losses grew to �1.38m, the expectation of a higher revenue didn�t materialise. Crucially, they have enough financing in place with Cash and cash equivalent at �6.74m. But, the company didn�t allude to net funds dropping from �7.07m to �3.8m in six months. Mostly due to increases in debt. Collagen paid deferred consideration of �1m to NZ based Southern Lights Biomaterials (an acquisition made in 2014) by drawing down a �1m bond with an interest rate of 10%. Bad news and lack of confidences from lenders. To understand 7 things Collagen Solutions, click http://bit.ly/2jgYt9o
Half yearly report gives some answers to the drop. Plenty of positives as well and as my previous 2019 it why i'm here . 12 months not long and plenty of news through 2018 to keep us interested. The completion of the ChondroMimetic� extension study in September is expected to provide headline results in Q1 2018 and we expect to be in a position to provide this data to prospective commercialisation partners moving into 2018.
I totally agree. Needs some attention to get it moving. Great products and doing well. Hopefully some good news soon.
IMO. They really seem on top of their game: https://www.youtube.com/watch?v=iYZ2bFA74DU
Just had a look at the Market Capitalization. This is the value of all the shares in issue. It is �10.79 million The company's assets are �20.29 million We could easily see a doubling of the price. Half year results on Dec 5th with the bad news already out there. There's only one way it can go :-)
You have this wrong. Cash in the bank accounts for 65% of the share price.
One of the problems we have in investing in small cap companies is the sp volatility. You can be up and down 10% in hours, is this down to manipulation or just small trades moving the prices? I just do not know about sp volatility but I felt the fundementals looked ok and I had some understanding of the use of collagen in cosmetic procedures. Ageing population may want more collagen!.
No, expect volatility but happy to wait a year. Would expect progress and better news in 2018.
quality prospect
nice buy easyp , hope your not all in. It might be prudent to buy in tranches as this look's like a slow burn. IMHO.
Collagen Solutions PLC appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total 8.98m. In fact, 0.65% of the value of Collagen Solutions PLC shares can be attributed to this cash. On the basis of the cash, the Directors buying and revenue I purchased �1500 worth (5 mins ago) as something of a speculative buy. Wish me luck! I hope to see a double digit return in less than 12 months.
had to have a dabble at that price.
your interested then.
and until funding clearer?
.....tomorrow.
Additionally, a key milestone was met in September when we completed patient assessments in our ongoing eight-year extension clinical study of ChondroMimetic osteochondral scaffold. The resulting data is due to be reported in Q1 2018, followed by a CE mark submission later in 2018, whilst now engaging in partnering discussions. We look forward to providing more detail of progress within the business when we report our Interim results." This is what i'm here for and 2019
Given the news this morning those watching or already invested need an explanation as to what is going on? I did not buy but was interested as many posts suggested the sp could quickly appreciate this year.
Given the news this morning those watching or already invested need an explanation as to what is going on? I did not buy but was interested as many posts suggested the sp could quickly appreciate this year.
perhaps not, but what price . looking to buy myself.
another placing?